Insider Transactions Reported by 14 Insiders of Akari Therapeutics Plc

Symbol
AKTX on Nasdaq
Location
Tampa, FL

Insiders trading volume in the past year

Akari Therapeutics Plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
M.D. Ph.D. Hoyoung Huh Director, 10%+ Owner $8,631,947 +$1,499,999 +21% 16 Dec 2025
Samir R. Patel Director, 10%+ Owner $7,904,201 +$343,750 +4.5% 16 Dec 2025
Raymond Prudo-Chlebosz Director $4,409,543 +$406,249 +10% 16 Dec 2025
Abizer Gaslightwala CEO, Director $982,195 +$494,159 +101% 16 Dec 2025
Sandip I. Patel Director $736,057 +$162,499 +28% 16 Dec 2025
Robert B. Bazemore Director $162,496 +$62,499 +63% 16 Dec 2025
James R. Neal Director $69,954 20 Mar 2025
Kameel D. Farag Interim CFO $29,963 +$9,999 +50% 16 Dec 2025
Torsten Hombeck Cfo $468 20 Mar 2025
DONALD A. WILLIAMS Director 28 Jun 2024
WENDY F. DICICCO Interim CFO 01 May 2024
Michael Grissinger Director 28 Jun 2024
Rachelle Suzanne Jacques Chief Executive Officer, Director 26 Apr 2024
Mohamed Wa'el Ahmed Hashad Director 28 Jun 2024

Recent Insider Transactions by Companies or Individuals for Akari Therapeutics Plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.